Select Region:
Select Language:

Description

Quibim has developed an app to automatically extract vascular-based imaging biomarkers to detect changes associated with increased tumor neoangiogenesis activity and aggressiveness.

The Pharmacokinetic (PKM) model used in the app helps detect neoplasms and quantifies tumor neoangiogenesis to stage cancer aggressiveness.

This tool is useful for the characterization of tumoral processes in the early detection, diagnosis, treatment response evaluation and follow-up of patients with cancer.

Diseases

  • Solid tumors
  • Prostate cancer
  • Rectal cancer
  • Endometrial cancer
  • Liver cancer
Logo Recurso Quibim

Can we help you?

Know More